Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic and Wegovy in 2023, a 500 percent increase from ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...

The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced the ...

Medications like Ozempic and Zepbound work to mimic GLP-1, a hormone that makes you feel full. But there are also ways to boost natural GLP-1 levels through diet and lifestyle habits.

A new study has found that 10-hydroxy-cis-12-octadecenoic acid (HYA), a metabolite derived from linoleic acid by gut microbiota, can help reduce ...

In this article, we will delve deeply into these questions, providing a comprehensive understanding of Retatrutyd, its ...